Nigeria has taken delivery of long-acting injectable lenacapavir (LEN) for HIV prevention, a development the Federal Ministry of Health says will broaden prevention options and help improve adherence among people at risk of infection.
The new injectable, approved by Muhammad Pate, Coordinating
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
